Rapid Micro Biosystems (RPID) Total Current Liabilities (2020 - 2026)

Rapid Micro Biosystems' Total Current Liabilities history runs 7 years deep, the most recent figure standing at $19.1 million for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 27.49% year-over-year to $19.1 million; the TTM figure through Mar 2026 stood at $19.1 million (up 27.49% YoY), while the FY2025 annual figure was $18.5 million, up 5.25% from the prior year.
• Total Current Liabilities came in at $19.1 million for Q1 2026 at Rapid Micro Biosystems, up from $18.5 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $19.1 million in Q1 2026 to a low of $12.8 million in Q2 2022.
• A 5-year average of $16.2 million and a median of $15.9 million in 2024 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities slipped 20.34% in 2022 and rose 27.49% in 2026, its largest moves.
• Rapid Micro Biosystems' Total Current Liabilities stood at $19.0 million in 2022, then dropped by 0.34% to $19.0 million in 2023, then decreased by 7.48% to $17.6 million in 2024, then gained by 5.25% to $18.5 million in 2025, then grew by 3.42% to $19.1 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $19.1 million, $18.5 million, and $16.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison